Discover 3,097 paid clinical trials in Worcester, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,097
Parkinson's Disease in Asian Americans
for
Parkinson's Disease
Location: Boston MA
Sponsor: Tufts University
Sex: All
Age: 18+
Code: NCT05532982
Recruiting
Caries Detection With Two Different Caries Detecting Devices
for
Caries,Dental
Location: Boston MA
Sponsor: Tufts University
Sex: All
Age: 21+
Code: NCT06152081
Recruiting
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
for
Sjögren's Syndrome
Location: Boston MA, Voorhees Township NJ, Trois-Rivieres,
Sponsor: Amgen
Sex: All
Age: 18+
Code: NCT06747949
Phase3, Recruiting
Changes in Skeletal Muscle Thickness in Patients With Acute Heart Failure
Location: Boston MA, Bristol CT, Middletown NY, Harris NY,
Sponsor: Nuo Therapeutics
Sex: All
Age: 18+
Code: NCT02352467
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
AMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis
for
ALS
Location: Boston MA, Philadelphia PA, Montreal,
Sponsor: Amylyx Pharmaceuticals Inc.
Sex: All
Age: 18+
Code: NCT06665165
Phase1, Recruiting
A Study to Learn About the Study Medicine Aztreonam-Avibactam (ATM-AVI) in Infants and Newborns Admitted in Hospitals With Bacterial Infection (CHERISH)
for
Gram-negative Bacterial Infection
Location: Boston MA, Durham NC, Indianapolis IN, Louisville KY,
Sponsor: Pfizer
Sex: All
Age: 0
Code: NCT06462235
Phase2, Recruiting
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
for
Myelodysplastic Syndrome
Location: Boston MA, Lebanon NH, Stony Brook NY, Livingston NJ,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06577441
Phase2, Recruiting
NEO100 and High-Grade Meningioma
for
Residual, Progressive or Recurrent Grade II or III Meningioma
Location: Boston MA, Dallas TX, Los Angeles CA, Santa Monica CA,
Sponsor: Neonc Technologies, Inc.
Sex: All
Age: 12+
Code: NCT05023018
Phase2, Recruiting
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis